Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing
January 17, 2022 (Davis, CA) – Botanical Solution Inc. (BSI), innovator of sustainable, consistent, and cost-effective Advanced Botanical Materials for
2022 will see pharma target nutraceutical products to tap into consumer spending on preventative health: CPhI Worldwide Report
Amsterdam, CPhI Worldwide – the world’s largest pharma event, which will be hosted at the Frankfurt Messe (1-3 November, 2022) – releases the final
How Effective Are Drugs in Treating Communication Disorders?
Speaking, hearing, and comprehending is how most of us communicate with the outside world, and being unable to do so
Synairgen announces global strategic partnership with Ashfield Engage
Southampton, UK: Synairgen plc (LSE: SNG), the respiratory company developing SNG001 (inhaled interferon-beta or IFN-beta) for the treatment of COVID-19
B-cell lymphoma clinical trials now open on the TrialWire Platform
ADELAIDE, AUS – TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform.
CPhI Predictions for 2022
CPhI Predictions for 2022: high manufacturing demand to constrain global ingredients, partnering options and available CDMO capacity. Continued stellar growth